Mounjaro vs Ozempic: A Balanced, Informational Comparison

At a high level, Mounjaro and Ozempic belong to the same broad family of injectable medicines that influence appetite and blood-sugar regulation, but they differ in their active substance, their mechanism, and the doses they come in. The summary below is neutral and educational; it is not a recommendation of either.

Active substance and mechanism

• Mounjaro contains tirzepatide. It is a dual GIP and GLP-1 receptor agonist, meaning it acts on two gut-hormone pathways involved in appetite, fullness and blood-sugar control.
• Ozempic contains semaglutide. It is a GLP-1 receptor agonist, acting on a single pathway.
• Wegovy also contains semaglutide — the same active substance as Ozempic — but is licensed and dosed for weight management rather than diabetes. People often ask about how Wegovy and Mounjaro compare for that reason, or the broader differences between Wegovy and Mounjaro.

How they are taken

Both are supplied as pre-filled pens and taken as a once-weekly subcutaneous injection (commonly into the abdomen, thigh or upper arm, with sites rotated each week). Both are typically started at a low dose and adjusted gradually over time by the prescriber.

• Mounjaro dose strengths commonly referenced are 2.5, 5, 7.5, 10, 12.5 and 15 mg. Many people see the 5 mg step as part of titration, and there is more context on the medicine itself on the Mounjaro overview.
• Ozempic dose strengths commonly referenced are 0.25, 0.5, 1 and 2 mg.
• Dose adjustments are individual and prescriber-led — never something to change on your own.

Licensed use

This is where the two diverge most clearly. Ozempic is licensed for adults with type 2 diabetes. Mounjaro is licensed for type 2 diabetes and, in many jurisdictions, for weight management in adults who meet specific criteria. Because licensing varies between countries, the relevant authority where you live (and your prescriber) is the source of truth — for example, the electronic Medicines Compendium publishes the official UK product information.

Side effects, in general terms

Both medicines share a broadly similar profile of commonly reported side effects, because both act on GLP-1 pathways. According to NHS patient information and the published product leaflets, the most commonly reported effects are gastrointestinal:

• Nausea, vomiting, diarrhoea, constipation
• Indigestion, reflux, burping
• Reduced appetite, occasional fatigue or headache
• Injection-site reactions

These are commonly reported, not universal, and many people find they ease as the body adjusts. If any symptom is severe, persistent or worrying, contact your healthcare professional promptly. Adverse effects can also be reported via your national reporting scheme (such as the UK's Yellow Card scheme). For a parallel breakdown, see side effects of Wegovy compared with Mounjaro.

Weight loss — what the question really means

One of the most searched comparisons is around weight outcomes. The honest, balanced answer: published clinical trial data for tirzepatide and semaglutide exist, but results vary significantly between individuals, depend on dose, dietary patterns, activity and many other factors, and any expectation about outcomes is a conversation for your prescriber — not something to infer from a comparison article. There is no guarantee with any medicine, and we won't pretend otherwise.

Cost, access and availability

Cost, availability and how these medicines are accessed vary widely from country to country and depend on the healthcare system, prescribing route and pharmacy involved. GLP Trackr doesn't publish prices and doesn't sell, supply or source either medicine — for cost and access questions, your prescriber and a registered pharmacy in your country are the right places to ask.

Related comparisons

If you arrived here trying to make sense of the wider GLP-1 landscape, these related pages cover the adjacent questions:

• Ozempic vs Mounjaro — the same comparison from the other angle
• Difference between Mounjaro and Ozempic — focused on the practical differences
• Mounjaro or Ozempic — framing the question as a prescriber conversation
• Ozempic vs Wegovy — same active substance, different licensed use
• Wegovy vs Ozempic — the reverse comparison
• Mounjaro vs Wegovy and Mounjaro or Wegovy — the closest weight-management comparison
• Wegovy or Mounjaro — the same question approached from prescribing context

GLP Trackr is designed to support either journey — Mounjaro or Ozempic (and Wegovy too) — without taking a side. The app is a companion for people already prescribed one of these medicines, and the choice of medicine is always one to make with your prescriber.

Comparison-friendly tracking, in one place

Because the two medicines share so much in common day-to-day (a weekly injection, rotating sites, an appetite that's changed, side effects that come and go), the same set of tracking habits supports either. In GLP Trackr you can:

• Log every weekly shot — date, time, dose strength and injection site — so the picture of your treatment is always complete
• Let the app suggest your next injection site, with rotation handled automatically
• Track side effects as they happen, then look back to see how patterns change with each dose stage
• Log food effortlessly with a photo scan or barcode, which is especially helpful when appetite is low
• See your weight, measurements and weekly progress come together as charts and insights
• Generate a doctor-ready report to bring to prescriber appointments — useful when you're discussing how things are going or whether your current treatment is right for you

Where to go from here

If you're exploring this topic as part of a wider GLP-1 decision your prescriber is helping you make, the Wegovy vs Mounjaro hub brings together the most-asked comparisons in one place. For purely informational reading on the medicine you're already on, the Mounjaro overview is a good neutral starting point.

A note on safety

The information on this page is general and educational. Mounjaro and Ozempic are prescription-only medicines under additional monitoring in many countries; any decision about which medicine, what dose, or whether to switch belongs with your prescriber, who knows your full history. If you experience side effects that are severe, persistent or out of the ordinary, contact your healthcare professional promptly rather than waiting.

Try GLP Trackr free

Whichever medicine you've been prescribed, GLP Trackr keeps your shots, food, weight and how you feel in one connected place — so you can focus on the journey, not the admin. Free for 7 days on the App Store and Google Play, with nothing to set up before you start.